StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV)
Equities researchers at StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a research note issued on Saturday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Separately, D. Boral Capital reaffirmed a “buy” rating and set a $9.00 target price on shares of MediciNova in a research note […]
Equities researchers at StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a research note issued on Saturday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Separately, D. Boral Capital reaffirmed a “buy” rating and set a $9.00 target price on shares of MediciNova in a research note […]
